Abbott's

Abbott's earnings excluding the costs exceeded analysts 'expectations, though the sales figure fell short -- a scenario similar to what unfolded in rival Johnson & Johnson 's earnings report Tuesday, when J & J cautioned that overall health-care spending growth was decelerating.

Abbott Profit Falls 40% on Acquisition, Recall Costs Peter Loftus 2010

There are pictures by name photographers, such as Berenice Abbott's famous sliver of a cityscape, "Financial District, c. 1932," and Paul Woolf's smog shrouded "City Symphony, c. 1935," with water tanks arrayed across the foreground like notes on a staff of music.

The Sky-Highs and Lows of City Scenes William Meyers 2010

In the case of Abbott's Meridia, the agency said the "very modest weight loss" from the drug didn't justify its cardiovascular risk.

FDA Rejects Orexigen-Takeda Diet Drug Thomas Gryta 2011

Sales of Abbott's nutritional products, which include Similac, declined 1.5% to $1.37 billion due to the product recall.

Abbott Profit Falls 40% on Acquisition, Recall Costs Peter Loftus 2010

Hannah VerdierAfter a closely mimicking the plots of its UK antecedent for the first four or so episodes, Shameless comes up with a storyline that deviates somewhat from Paul Abbott's original, with Frank Gallagher swearing off alcohol for a fortnight in order to earn $3,000.

TV highlights 11/08/2011: The Culture Show At The Edinburgh Festival | Torchwood: Miracle Day | The Killing | The Forgotten Blitz | Little Box Of Horrors | Shameless US 2011

In addition, the layoffs affect some workers in Abbott's diagnostics and pharmaceutical manufacturing operations, Mr. Stoffel said.

Abbott's Earnings Rise Peter Loftus 2012

For the fourth quarter, Abbott's profit rose to $1.6 billion, or $1.02 a share, from $1.4 billion, or 92 cents a share, a year earlier.

Abbott's Earnings Rise Peter Loftus 2012

The company attributed some of the layoffs to the impending mid-2012 expiration of Abbott's contract to supply the artery-opening stent Promus to Boston Scientific Corp. Boston Scientific is shifting to a new version of Promus that it will manufacture internally.

Abbott's Earnings Rise Peter Loftus 2012

Abbott's forecast implies an increase in earnings excluding certain items of about 7%, down from double-digit growth over the past five years.

Abbott's Earnings Rise Peter Loftus 2012

A key product, he says, is Abbott's PathVysion test, which measures the HER-2 gene, a primary target for the breast cancer drug Herceptin, made by Roche.

Companies Aim to Personalize Therapy Goran Mijuk 2010